BUY Chennai Petroleum Corporation Limited — IDBI Capital
byIDBI CapitalHorizon: NA (inferred 1–3 months)2 Nov 2026via IDBI Capital Research Calls Telegram
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
5 advisors have active swing BUY calls on this stock, all issued in the last 14 days
Advisor consensus · adjacent horizon·30 Oct · 6d ago
Chennai Petroleum reported Q2 FY2026-27 PAT of ₹2,271 crore compared to ₹732 crore in the same quarter last year, with revenue of ₹22,109 crore and an interim dividend of ₹25 per share.
NSE · Press Release·22 Oct · 2w ago
Chennai Petroleum reported Q2 FY27 revenue of ₹22,109 crore and PAT of ₹2,271 crore, significantly up from ₹732 crore in the same quarter last year. The company also declared an interim dividend of ₹2
BSE · Company Update·22 Oct · 2w ago
Chennai Petroleum reported Q2 FY27 PAT of ₹2,271 crore compared to ₹732 crore in the same quarter last year, with revenue at ₹22,109 crore. The company also declared an interim dividend of ₹25 per sha
BSE · Company Update·22 Oct · 2w ago
Chennai Petro Q2 Results: Profit doubles, margins expand; GRMs higher than MRPL
NewsCnbc-Tv18·22 Oct · 2w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Chennai Petroleum Corporation
- BUY — IDBI Capital4 Nov 2026 · ~2 weeks · target ₹1,680 · SL hit
- BUY — Ashish Kyal, Waves Strategy Advisors2 Nov 2026 · ~2 weeks · target ₹1,700 · SL hit
- BUY — Deven Mehata, IDBI Capital Markets and Securities30 Oct 2026 · ~2 weeks · target ₹1,670 · Active
- BUY — Vaishali Parekh, Prabhudas Lilladher28 Oct 2026 · ~2 weeks · target ₹1,650 · Active
- BUY — Ruchit Jain, Motilal Oswal26 Oct 2026 · ~2 weeks · target ₹1,700 · Expired
More from IDBI Capital
- BUY Alkem Laboratories6 Nov 2026 · ~2 weeks · target ₹5,460 · Active
- BUY Onesource Specialty Pharma6 Nov 2026 · ~2 weeks · target ₹1,735 · Active
- BUY Sun Pharmaceutical Industries6 Nov 2026 · ~2 weeks · target ₹1,925 · Active
- BUY Vijaya Diagnostic Centre6 Nov 2026 · ~2 weeks · target ₹1,575 · Active
- BUY Rolex Rings6 Nov 2026 · ~1 year · target ₹241 · Active

